Moderna, mRNA and Bird Flu

Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, alongside other influenza vaccines, health officials announced Friday.
Moderna Gets $590 Million from US to Study Bird Flu Vaccine
Moderna Inc. was awarded an additional $590 million from the US government to help the company develop a vaccine aimed at protecting people from bird flu.Most Read from BloombergThese Homes Withstood the LA Fires.
US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
Georgia halts poultry sales; HHS allocates $590M for flu vaccines
Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 million to Moderna to develop vaccines to protect people from flu strains in bird
Moderna: Can They Benefit From Bird Flu? (Rating Upgrade)
Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads significantly. Read my MRNA analysis.
HHS invests nearly $600 million in Moderna’s bird flu vaccine development
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.
Moderna May Have The Best Shot At A Vaccine For Stomach Flu
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
Is Moderna Stock a Buy?
Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...
Investor's Business Daily on MSN5d
Moderna Crashes 17%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting ...
Moderna's $1 Billion Revenue Forecast Cut Sends Stock Plummeting Over 20%
Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first bird-flu death ...
PharmiWeb1d
Moderna Announces Updates on Pandemic Influenza Program
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the ...
Q4 Earnings Estimate for Moderna Issued By Leerink Partnrs
Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...
FiercePharma11d
After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
Investor's Business Daily on MSN4d
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Moderna stock took a beating in January after the company slashed its outlook for 2024 and 2025 and missed the mark in a CMV ...